Immunology

  1. In-vivo Protection from SARS-CoV-2 infection by ATN-161 in k18-hACE2 transgenic mice

    1. Narayanappa Amruta
    2. Elizabeth B. Engler-Chiurazzi
    3. Isabel C. Murray-Brown
    4. Timothy E. Gressett
    5. Ifechukwude J. Biose
    6. Wesley H. Chastain
    7. Gregory Bix

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  2. SARS-CoV-2 ferritin nanoparticle vaccines elicit broad SARS coronavirus immunogenicity

    1. M. Gordon Joyce
    2. Wei-Hung Chen
    3. Rajeshwer S. Sankhala
    4. Agnes Hajduczki
    5. Paul V. Thomas
    6. Misook Choe
    7. Elizabeth J. Martinez
    8. William C. Chang
    9. Caroline E. Peterson
    10. Elaine B. Morrison
    11. Clayton Smith
    12. Rita E. Chen
    13. Aslaa Ahmed
    14. Lindsay Wieczorek
    15. Alexander Anderson
    16. James Brett Case
    17. Yifan Li
    18. Therese Oertel
    19. Lorean Rosado
    20. Akshaya Ganesh
    21. Connor Whalen
    22. Joshua M. Carmen
    23. Letzibeth Mendez-Rivera
    24. Christopher P. Karch
    25. Neelakshi Gohain
    26. Zuzana Villar
    27. David McCurdy
    28. Zoltan Beck
    29. Jiae Kim
    30. Shikha Shrivastava
    31. Ousman Jobe
    32. Vincent Dussupt
    33. Sebastian Molnar
    34. Ursula Tran
    35. Chandrika B. Kannadka
    36. Sandrine Soman
    37. Caitlin Kuklis
    38. Michelle Zemil
    39. Htet Khanh
    40. Weimin Wu
    41. Matthew A. Cole
    42. Debra K. Duso
    43. Larry W. Kummer
    44. Tricia J. Lang
    45. Shania E. Muncil
    46. Jeffrey R. Currier
    47. Shelly J. Krebs
    48. Victoria R. Polonis
    49. Saravanan Rajan
    50. Patrick M. McTamney
    51. Mark T. Esser
    52. William W. Reiley
    53. Morgane Rolland
    54. Natalia de Val
    55. Michael S. Diamond
    56. Gregory D. Gromowski
    57. Gary R. Matyas
    58. Mangala Rao
    59. Nelson L. Michael
    60. Kayvon Modjarrad

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  3. Durable antibody responses in staff at two long-term care facilities, during and post SARS-CoV-2 outbreaks

    1. Emily N. Gallichotte
    2. Mary Nehring
    3. Michael C. Young
    4. Sierra Pugh
    5. Nicole R. Sexton
    6. Emily Fitzmeyer
    7. Kendra M. Quicke
    8. Megan Richardson
    9. Kristy L. Pabilonia
    10. Nicole Ehrhart
    11. Bailey K. Fosdick
    12. Sue VandeWoude
    13. Gregory D. Ebel

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  4. Development of Potent and Effective Synthetic SARS-CoV-2 Neutralizing Nanobodies

    1. Maxwell A. Stefan
    2. Yooli K. Light
    3. Jennifer L. Schwedler
    4. Peter R. McIlroy
    5. Colleen M. Courtney
    6. Edwin A. Saada
    7. Christine E. Thatcher
    8. Ashlee M. Phillips
    9. Feliza A. Bourguet
    10. Catherine M. Mageeney
    11. Summer A. McCloy
    12. Nicole M. Collette
    13. Oscar A. Negrete
    14. Joseph S. Schoeniger
    15. Dina R. Weilhammer
    16. Brooke Harmon

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  5. Infection and vaccine-induced neutralizing antibody responses to the SARS-CoV-2 B.1.617.1 variant

    1. Venkata-Viswanadh Edara
    2. Lilin Lai
    3. Malaya K. Sahoo
    4. Katharine Floyd
    5. Mamdouh Sibai
    6. Daniel Solis
    7. Maria W. Flowers
    8. Laila Hussaini
    9. Caroline Rose Ciric
    10. Sarah Bechnack
    11. Kathy Stephens
    12. Elham Bayat Mokhtari
    13. Prakriti Mudvari
    14. Adrian Creanga
    15. Amarendra Pegu
    16. Alexandrine Derrien-Colemyn
    17. Amy R. Henry
    18. Matthew Gagne
    19. Barney S. Graham
    20. Jens Wrammert
    21. Daniel C. Douek
    22. Eli Boritz
    23. Benjamin A. Pinsky
    24. Mehul S. Suthar

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  6. Highly functional Cellular Immunity in SARS-CoV-2 Non-Seroconvertors is associated with immune protection

    1. Athina Kilpeläinen
    2. Esther Jimenez-Moyano
    3. Oscar Blanch-Lombarte
    4. Dan Ouchi
    5. Ruth Peña
    6. Bibiana Quirant-Sanchez
    7. Anna Chamorro
    8. Ignacio Blanco
    9. Eva Martínez-Caceres
    10. Roger Paredes
    11. Lourdes Mateu
    12. Jorge Carrillo
    13. Julià Blanco
    14. Christian Brander
    15. Marta Massanella
    16. Bonaventura Clotet
    17. Julia G. Prado

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  7. Protective heterologous T cell immunity in COVID-19 induced by the trivalent MMR and Tdap vaccine antigens

    1. Vijayashree Mysore
    2. Xavier Cullere
    3. Matthew L. Settles
    4. Xinge Ji
    5. Michael W. Kattan
    6. Michaël Desjardins
    7. Blythe Durbin-Johnson
    8. Tal Gilboa
    9. Lindsey R. Baden
    10. David R. Walt
    11. Andrew H. Lichtman
    12. Lara Jehi
    13. Tanya N. Mayadas

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  8. Naturally enhanced neutralizing breadth to SARS-CoV-2 after one year

    1. Zijun Wang
    2. Frauke Muecksch
    3. Dennis Schaefer-Babajew
    4. Shlomo Finkin
    5. Charlotte Viant
    6. Christian Gaebler
    7. Hans-Heinrich Hoffmann
    8. Christopher O. Barnes
    9. Melissa Cipolla
    10. Victor Ramos
    11. Thiago Y. Oliveira
    12. Alice Cho
    13. Fabian Schmidt
    14. Justin da Silva
    15. Eva Bednarski
    16. Lauren Aguado
    17. Jim Yee
    18. Mridushi Daga
    19. Martina Turroja
    20. Katrina G. Millard
    21. Mila Jankovic
    22. Anna Gazumyan
    23. Zhen Zhao
    24. Charles M. Rice
    25. Paul D. Bieniasz
    26. Marina Caskey
    27. Theodora Hatziioannou
    28. Michel C. Nussenzweig

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  9. The immunological factors predisposing to severe COVID-19 are already present in healthy elderly and men

    1. Gizem Kilic
    2. Ozlem Bulut
    3. Martin Jaeger
    4. Rob ter Horst
    5. Valerie A. C. M. Koeken
    6. Simone Moorlag
    7. Vera P. Mourits
    8. Charlotte de Bree
    9. Jorge Domínguez-Andrés
    10. Leo A. B. Joosten
    11. Mihai G. Netea

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  10. Preliminary Immunogenicity of a Pan-COVID-19 T Cell Vaccine in HLA-A*02:01 Mice

    1. Brandon Carter
    2. Jinjin Chen
    3. Clarety Kaseke
    4. Alexander Dimitrakakis
    5. Gaurav D. Gaiha
    6. Qiaobing Xu
    7. David K. Gifford

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity
Previous Page 116 of 174 Next